Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Mortensen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Immunology|April 1, 1981
Quantitative differences between complement factor-B phenotypesJ P Mortensen, L U Lamm
Immunology|April 1, 1980
Studies on the C2-deficiency gene in manJ P Mortensen, L Buskjaer, L U Lamm
Human Genetics|January 1, 1981
Family studies of complement C4 and HLA in manG Bruun-Petersen, L U Lamm, I J Sørensen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2006
Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancerP Pfeiffer, J P Mortensen, B Bjerregaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracilP Pfeiffer, H Sørbye, H Ehrsson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Immunology|April 1, 1981
Quantitative differences between complement factor-B phenotypesJ P Mortensen, L U Lamm
Immunology|April 1, 1980
Studies on the C2-deficiency gene in manJ P Mortensen, L Buskjaer, L U Lamm
Human Genetics|January 1, 1981
Family studies of complement C4 and HLA in manG Bruun-Petersen, L U Lamm, I J Sørensen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2006
Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancerP Pfeiffer, J P Mortensen, B Bjerregaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracilP Pfeiffer, H Sørbye, H Ehrsson, et al.
Pageof 1